Advertisement

Topics

Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects

20:00 EDT 16 Apr 2019 | AAAS

(Institute for Quality and Efficiency in Health Care) Study indicates longer overall survival of postmenopausal women. However, there is a higher frequency of severe diseases of blood and lymphatic system. Overall, added benefit not proven.

Original Article: Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects

NEXT ARTICLE

More From BioPortfolio on "Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...